Home > Medical Reference > Encyclopedia (English)

Please install flash player to see this video.

Hospital Virtual Tour

Related Content

Pronunciation:

(hal SIN oh nide)

U.S. Brand Names:

Halog®; Halog®-E [DSC]

Generic Available:

Canadian Brand Names:

Halog®

Use:

Inflammation of corticosteroid-responsive dermatoses [high potency topical corticosteroid]

Pregnancy Risk Factor:

Contraindications:

Hypersensitivity to halcinonide or any component of the formulation; viral, fungal, or tubercular skin lesions

Warnings/Precautions:

Adverse systemic effects may occur when used on large areas of the body, denuded areas, for prolonged periods of time, with an occlusive dressing, and/or in infants or small children

Adverse Reactions:

Frequency not defined: Dermatologic: Itching; dry skin; folliculitis; hypertrichosis; acneiform eruptions; hypopigmentation; perioral dermatitis; allergic contact dermatitis; skin maceration; skin atrophy; striae; local burning, irritation, miliaria; secondary infection

Overdosage/Toxicology:

When consumed in excessive quantities, systemic hypercorticism and adrenal suppression may occur; in those cases, discontinuation and withdrawal of the corticosteroid should be done judiciously

Drug Interactions:

No data reported

Mechanism of Action:

Decreases inflammation by suppression of migration of polymorphonuclear leukocytes and reversal of increased capillary permeability

Pharmacodynamics/Kinetics:

Absorption: Percutaneous absorption varies by location of topical application and use of occlusive dressings

Metabolism: Primarily hepatic

Excretion: Urine

Dosage:

Children and Adults: Topical: Steroid-responsive dermatoses: Apply sparingly 1-3 times/day, occlusive dressing may be used for severe or resistant dermatoses; a thin film is effective; do not overuse. Therapy should be discontinued when control is achieved; if no improvement is seen, reassessment of diagnosis may be necessary.

Patient Education:

For external use only. Do not use for eyes, mucous membranes, or open wounds. Use exactly as directed and for no longer than the period prescribed. Before using, wash and dry area gently. Apply in a thin layer (may rub in lightly). Apply light dressing (if necessary) to area being treated. Do not use occlusive dressing unless so advised by prescriber. Avoid prolonged or excessive use around sensitive tissues, genital, or rectal areas. Avoid exposing treated area to direct sunlight. Inform prescriber if condition worsens (redness, swelling, irritation, signs of infection, or open sores) or fails to improve. Pregnancy precaution: Inform prescriber if you are or intend to become pregnant.

Nursing Implications:

A thin film is effective; do not overuse; do not use tight-fitting diapers or plastic pants on children being treated in the diaper area; use only as prescribed, and for no longer than the period prescribed; apply sparingly in light film; rub in lightly; avoid contact with eyes; notify physician if condition being treated persists or worsens

Dental Health: Effects on Dental Treatment:

No significant effects or complications reported

Dental Health: Vasoconstrictor/Local Anesthetic Precautions:

No information available to require special precautions

Mental Health: Effects on Mental Status:

None reported

Mental Health: Effects on Psychiatric Treatment:

None reported

Dosage Forms:

[DSC] = Discontinued product

Cream (Halog®): 0.1% (15 g, 30 g, 60 g, 240 g)

Cream, emollient base (Halog®-E): 0.1% (30 g, 60 g) [DSC]

Ointment (Halog®): 0.1% (15 g, 30 g, 60 g, 240 g)

Solution, topical (Halog®): 0.1% (20 mL, 60 mL)

International Brand Names:

Betacorton® (CH, CZ, TR); Cortilate® (IN); Dermalog® (BD, MX); Halciderm® (GB, IT, NL); Halog® (AT, BR, CA, CN, DE, ES, ID); Velog® (BD); Volog® (TR)

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.